MuleSoft, Inc. – Trademark Portfolio
Entity Type: 03
MuleSoft, Inc. holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 9 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 4 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include M, MULE, RAML, ANYPOINT, and MULESOFT. The owner is based in San Franscisco, CA.
77 Geary Street, Suite 400
San Franscisco, CA 94108
Showing of trademarks Trademarks
Trademark Classifications
MuleSoft, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does MuleSoft, Inc. have?
MuleSoft, Inc. has 11 U.S. trademarks filed with the USPTO. Of these, 7 registered, 2 abandoned, 2 cancelled.
What trademark classes does MuleSoft, Inc. file in?
MuleSoft, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 35 (Advertising & Business), Class 38 (Telecommunications). Class 42 covers scientific and technological services; industrial analysis and research services.
What are MuleSoft, Inc.'s most well-known trademarks?
MuleSoft, Inc.'s registered trademark portfolio includes well-known marks such as M, MULE, RAML, ANYPOINT, and MULESOFT. These are among 7 currently registered trademarks in the portfolio.
What is MuleSoft, Inc.'s trademark registration success rate?
MuleSoft, Inc. has a 64% trademark registration rate, with 7 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.